| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.66 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |